While some osteoarthritis models suggest TRPC5 inhibition leads to more inflammation and pain, other researchers saw reversed touch pain in mice models of sickle cell disease, migraine, chemotherapy-related pain, and surgical pain after TRPC5 inhibition [58]. This evidence concerns the gene TRPC5 and sickle cell disease.